Lethal faciocardiomelic dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1972OMIM:227270Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Lethal faciocardiomelic dysplasia, also known as lethal facio-cardio-melic syndrome, is an extremely rare genetic condition that affects multiple parts of the body, including the face, heart, and limbs. The name itself describes the key areas involved: 'facio' refers to the face, 'cardio' to the heart, and 'melic' to the limbs. This condition is present at birth and is unfortunately fatal, typically in the newborn period or shortly after. Babies born with this condition typically have distinctive facial features, serious heart defects (congenital heart malformations), and significant abnormalities of the arms and legs, including underdeveloped or missing bones. Additional features may include abnormalities of the nose, mouth, and other structures. The heart defects are often severe and contribute significantly to the poor outcome. Because this condition is lethal, treatment is primarily supportive and focused on comfort care. There are no curative treatments available. Only a very small number of cases have been described in the medical literature, making this one of the rarest known genetic conditions. Genetic counseling is important for affected families to understand recurrence risks in future pregnancies.

Key symptoms:

Severe heart defects present at birthAbnormal facial featuresUnderdeveloped or missing limb bonesShort limbsFlat or underdeveloped noseSmall jawAbnormalities of the hands and fingersAbnormalities of the feet and toesCleft palate or lip abnormalitiesBreathing difficulties at birthLow birth weightFailure to thrive

Clinical phenotype terms (15)— hover any for plain English
MicroglossiaHP:0000171Fibular hypoplasiaHP:0003038Radial ray deficiencyHP:0006433Short tibiaHP:0005736Short 5th fingerHP:0009237
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Lethal faciocardiomelic dysplasia.

View clinical trials →

No actively recruiting trials found for Lethal faciocardiomelic dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Lethal faciocardiomelic dysplasia community →

No specialists are currently listed for Lethal faciocardiomelic dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Lethal faciocardiomelic dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Lethal faciocardiomelic dysplasiaForum →

No community posts yet. Be the first to share your experience with Lethal faciocardiomelic dysplasia.

Start the conversation →

Latest news about Lethal faciocardiomelic dysplasia

No recent news articles for Lethal faciocardiomelic dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Can you explain exactly what abnormalities have been found in our baby?,Is genetic testing available to identify the specific cause of this condition?,What is the chance this could happen again in a future pregnancy?,What palliative care and comfort measures are available for our baby?,Can we be referred to a genetic counselor to discuss family planning?,Are there any support groups or bereavement services you can recommend?,Is prenatal testing possible in future pregnancies to check for this condition?

Common questions about Lethal faciocardiomelic dysplasia

What is Lethal faciocardiomelic dysplasia?

Lethal faciocardiomelic dysplasia, also known as lethal facio-cardio-melic syndrome, is an extremely rare genetic condition that affects multiple parts of the body, including the face, heart, and limbs. The name itself describes the key areas involved: 'facio' refers to the face, 'cardio' to the heart, and 'melic' to the limbs. This condition is present at birth and is unfortunately fatal, typically in the newborn period or shortly after. Babies born with this condition typically have distinctive facial features, serious heart defects (congenital heart malformations), and significant abnormal

How is Lethal faciocardiomelic dysplasia inherited?

Lethal faciocardiomelic dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Lethal faciocardiomelic dysplasia typically begin?

Typical onset of Lethal faciocardiomelic dysplasia is neonatal. Age of onset can vary across affected individuals.